Details for New Drug Application (NDA): 078263
✉ Email this page to a colleague
NDA 078263 describes PERINDOPRIL ERBUMINE, which is a drug marketed by Ani Pharms, Apotex, Aurobindo Pharma, Hikma, and Lupin Ltd, and is included in five NDAs. It is available from one supplier. Additional details are available on the PERINDOPRIL ERBUMINE profile page.
The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perindopril erbumine profile page.
The generic ingredient in PERINDOPRIL ERBUMINE is perindopril erbumine. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the perindopril erbumine profile page.
Summary for 078263
| Tradename: | PERINDOPRIL ERBUMINE |
| Applicant: | Lupin Ltd |
| Ingredient: | perindopril erbumine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 078263
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jan 27, 2010 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | Jan 27, 2010 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 8MG | ||||
| Approval Date: | Jan 27, 2010 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
